Cell and gene therapy: The vital role of logistics
By 2030, the cell and gene therapy market is projected to be worth £76.03bn, with a substantial compound annual growth rate of 44%. This major growth not only represents a market opportunity but also a logistical challenge unlike any other in healthcare. With investments in the billions of dollars, how will the industry overcome the bottlenecks associated with transportation and regulatory compliance that could potentially threaten this potential?
